Deoxymab Oncology Candidate
Solid Tumor Cancer
PreclinicalActive
Key Facts
About Patrys
Patrys leverages a reformulated quetiapine IV and a novel deoxymab platform to address unmet needs in delirium and oncology.
View full company profileTherapeutic Areas
Other Solid Tumor Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| EI-012 | Elixiron Immunotherapeutics | Preclinical |